RUNX3 and cancer: RUNX proteins not only activate their direct target genes, but also interact with many other TFs involved in various signaling pathways to modulate the development and progression of cancer [24,37,38,39], such as the ability of RUNX3 to directly interact and suppress the activity of the β-catenin/TCF4 complex [40,41].